RSL Revolutionary Labs Ltd, the Cypriot biotechnology company behind the innovative dermaceutical line εὖSKIN, has announced its expansion into Sub-Saharan Africa through a strategic partnership with Eshe Women’s Health & Well-Being App, a creative digital solution building the largest women’s community in Africa and advancing women’s health and empowerment.
The initial rollout covers Kenya, Nigeria, and South Africa, the company's announcement notes.
"This collaboration marks a significant milestone in RSL’s mission to improve the quality of life for oncology patients worldwide. By combining εὖSKIN®’s science-backed formulations, blending over 15 natural ingredients with advanced biomaterials like atelocollagen and hyaluronic acid, with Eshe’s deep reach and commitment to women’s wellness, the partnership promises to deliver accessible, effective skincare solutions to cancer patients in Africa and all those who want to nurture their skin," the announcement continues.
"Africa is home to some of the most resilient and inspiring women in the world," said Dr. Marianna Prokopi–Demetriades, Co-founder of RSL Revolutionary Labs Ltd. "Our partnership with Eshe Women’s Health & Well-Being App is about more than distribution, it’s about creating meaningful impact. Together, we are ensuring that oncology patients receive high-quality supportive care while also championing initiatives that empower women and communities."
Eshe Women’s Health & Well-Being App, known for its women’s health empowerment programmes and community-driven initiatives, will leverage its network to ensure wider availability, faster delivery, and stronger awareness campaigns around skin and supportive oncology care across Sub-Saharan Africa, starting in Kenya, Nigeria, and South Africa.
“We are proud to partner with RSL Revolutionary Labs Ltd to bring εὖSKIN across Sub-Saharan Africa-starting with Kenya, Nigeria, and South Africa,” said Viktoriya Henkelmann, Co-Founder at Eshe Women’s Health & Well-Being App. “Our mission has always been to uplift women and provide access to tools that improve health and dignity. This collaboration perfectly aligns with that vision.”
